ArticleMicrobial cell factories2012
Lactic Acid Bacteria: a promising alternative for recombinant protein production.
Article in Microbial cell factories, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- EngineeredFrontiers in immunology · 2026Article
- Therapeutic potential ofJournal of advanced veterinary and animal research · 2026Article
- Genome-Driven Insights intoBiology · 2025Article
- Functional expression and secretion of basic fibroblast growth factor inFrontiers in bioengineering and biotechnology · 2025Article
- The strain-dependent cytostatic activity of Lactococcus lactis on CRC cell lines is mediated through the release of arginine deiminase.Microbial cell factories · 2024Article
- Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ EnterotoxigenicVaccines · 2024Article
- Induced Expression of theToxins · 2023Article
- DoesCancers · 2022Review
- The B1 Domain of Streptococcal Protein G Serves as a Multi-Functional Tag for Recombinant Protein Production in Plants.Frontiers in plant science · 2022Article
- The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off.Animals : an open access journal from MDPI · 2021Article
- Probiotic engineering strategies for the heterologous production of antimicrobial peptides.Advanced drug delivery reviews · 2021Review
- Nasally AdministeredAntioxidants (Basel, Switzerland) · 2020Article
- Development of CRISPR Interference (CRISPRi) Platform for Metabolic Engineering ofInternational journal of molecular sciences · 2020Article
- The Practical Potential of Bacilli and Their Enzymes for Industrial Production.Frontiers in microbiology · 2020Review
- Antifungal Peptides as Therapeutic Agents.Frontiers in cellular and infection microbiology · 2020Review
- Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis.BMC biotechnology · 2019Article
- A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates.Scientific reports · 2018Article
- Getting value from the waste: recombinant production of a sweet protein by Lactococcus lactis grown on cheese whey.Microbial cell factories · 2018Article
- Development of bicistronic expression system for the enhanced and reliable production of recombinant proteins in Leuconostoc citreum.Scientific reports · 2018Article
- Substrate sustained release-based high efficacy biosynthesis of GABA by Lactobacillus brevis NCL912.Microbial cell factories · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.